Literature DB >> 28100614

Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor.

Nicole Lewis-Rogers1, Jon Seger2, Frederick R Adler2,3.   

Abstract

Rhinoviruses are the most common causes of the common cold. Their many distinct lineages fall into "major" and "minor" groups that use different cell surface receptors to enter host cells. Minor-group rhinoviruses are more immunogenic in laboratory studies, although their patterns of transmission and their cold symptoms are broadly similar to those of the major group. Here we present evolutionary evidence that minor-group viruses are also more immunogenic in humans. A key finding is that rates of amino acid substitutions at exposed sites in the capsid proteins VP2, VP3, and VP1 tend to be elevated in minor-group relative to major-group viruses, while rates at buried sites show no consistent differences. A reanalysis of historical virus watch data also indicates a higher immunogenicity of minor-group viruses, consistent with our findings about evolutionary rates at amino acid positions most directly exposed to immune surveillance. The increased immunogenicity and speed of evolution in minor-group lineages may contribute to the very large numbers of rhinovirus serotypes that coexist while differing in virulence.IMPORTANCE Most colds are caused by rhinoviruses (RVs). Those caused by a subset known as the minor-group members of rhinovirus species A (RV-A) are correlated with the inception and aggravation of asthma in at-risk populations. Genetically, minor-group viruses are similar to major-group RV-A, from which they were derived, although they tend to elicit stronger immune responses. Differences in their rates and patterns of molecular evolution should be highly relevant to their epidemiology. All RV-A strains show high rates of amino acid substitutions in the capsid proteins at exposed sites not previously identified as being immunogenic, and this increase is significantly greater in minor-group viruses. These findings will inform future studies of the recently discovered RV-C, which also appears to exacerbate asthma in adults and children. In addition, these findings draw attention to the difficult problem of explaining the long-term coexistence of many serotypes of major- and minor-group RVs.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  human rhinovirus; immunogenicity; major-group rhinoviruses; minor-group rhinoviruses; molecular evolution

Mesh:

Substances:

Year:  2017        PMID: 28100614      PMCID: PMC5355621          DOI: 10.1128/JVI.01659-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Positive selection of synonymous mutations in vesicular stomatitis virus.

Authors:  I S Novella; S Zárate; D Metzgar; B E Ebendick-Corpus
Journal:  J Mol Biol       Date:  2004-10-01       Impact factor: 5.469

2.  Rhinoviruses in Britain 1963-1973.

Authors:  M O Roebuck
Journal:  J Hyg (Lond)       Date:  1976-02

Review 3.  Antigenic structure of picornaviruses.

Authors:  P D Minor
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  The Tecumseh study of respiratory illness. IV. Prevalence of rhinovirus serotypes, 1966-1969.

Authors:  A S Monto; J J Cavallaro
Journal:  Am J Epidemiol       Date:  1972-11       Impact factor: 4.897

Review 5.  Antibody recognition of picornaviruses and escape from neutralization: a structural view.

Authors:  M G Mateu
Journal:  Virus Res       Date:  1995-09       Impact factor: 3.303

6.  Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells.

Authors:  Julie R Harris; Vincent R Racaniello
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Phylogenetic relationships and molecular adaptation dynamics of human rhinoviruses.

Authors:  Nicole Lewis-Rogers; Matthew L Bendall; Keith A Crandall
Journal:  Mol Biol Evol       Date:  2009-01-30       Impact factor: 16.240

Review 8.  A new concept of the epidemic process of influenza A virus.

Authors:  R E Hope-Simpson; D B Golubev
Journal:  Epidemiol Infect       Date:  1987-08       Impact factor: 2.451

Review 9.  Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development.

Authors:  Zuzana Staneková; Eva Varečková
Journal:  Virol J       Date:  2010-11-30       Impact factor: 4.099

10.  Rhinoviruses.

Authors:  J M Gwaltney
Journal:  Yale J Biol Med       Date:  1975-03
View more
  6 in total

1.  Identification of the Bartonella autotransporter CFA as a protective antigen and hypervariable target of neutralizing antibodies in mice.

Authors:  Lena K Siewert; Aleksandr Korotaev; Jaroslaw Sedzicki; Katja Fromm; Daniel D Pinschewer; Christoph Dehio
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-17       Impact factor: 12.779

2.  Epidemiology of rhinovirus under the COVID-19 pandemic in Guangzhou, China, 2020.

Authors:  Jianyun Lu; Tiantian Wu; Qing Zeng; Yiyun Chen; Yanhui Liu; Di Wu
Journal:  Immun Inflamm Dis       Date:  2022-06

3.  Cryo-EM structure of rhinovirus C15a bound to its cadherin-related protein 3 receptor.

Authors:  Yingyuan Sun; Kelly Watters; Marchel G Hill; Qianglin Fang; Yue Liu; Richard J Kuhn; Thomas Klose; Michael G Rossmann; Ann C Palmenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

4.  Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine.

Authors:  Christopher C Stobart; Jenna M Nosek; Martin L Moore
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

Review 5.  Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies.

Authors:  Kak-Ming Ling; Luke W Garratt; Timo Lassmann; Stephen M Stick; Anthony Kicic
Journal:  Front Pharmacol       Date:  2018-11-07       Impact factor: 5.810

6.  Molecular Epidemiology of Human Rhinovirus From 1-Year Surveillance Within a School Setting in Rural Coastal Kenya.

Authors:  Martha M Luka; Everlyn Kamau; Irene Adema; Patrick K Munywoki; Grieven P Otieno; Elijah Gicheru; Alex Gichuki; Nelson Kibinge; Charles N Agoti; D James Nokes
Journal:  Open Forum Infect Dis       Date:  2020-08-27       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.